ATE216587T1 - Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments - Google Patents

Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments

Info

Publication number
ATE216587T1
ATE216587T1 AT98958285T AT98958285T ATE216587T1 AT E216587 T1 ATE216587 T1 AT E216587T1 AT 98958285 T AT98958285 T AT 98958285T AT 98958285 T AT98958285 T AT 98958285T AT E216587 T1 ATE216587 T1 AT E216587T1
Authority
AT
Austria
Prior art keywords
ginkgo biloba
medication
produce
biloba extracts
extracts
Prior art date
Application number
AT98958285T
Other languages
English (en)
Inventor
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE216587T1 publication Critical patent/ATE216587T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT98958285T 1997-12-03 1998-12-01 Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments ATE216587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715230A FR2771639B1 (fr) 1997-12-03 1997-12-03 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
PCT/FR1998/002576 WO1999027943A1 (fr) 1997-12-03 1998-12-01 Utilisation d'extraits de ginkgo biloba pour preparer un medicament

Publications (1)

Publication Number Publication Date
ATE216587T1 true ATE216587T1 (de) 2002-05-15

Family

ID=9514108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98958285T ATE216587T1 (de) 1997-12-03 1998-12-01 Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments

Country Status (21)

Country Link
US (2) US6936285B1 (de)
EP (1) EP1035858B1 (de)
JP (1) JP2001524528A (de)
KR (1) KR100597139B1 (de)
CN (1) CN1188141C (de)
AT (1) ATE216587T1 (de)
AU (1) AU749752B2 (de)
CA (1) CA2312856C (de)
CZ (1) CZ299427B6 (de)
DE (1) DE69805096T2 (de)
DK (1) DK1035858T3 (de)
ES (1) ES2177097T3 (de)
FR (1) FR2771639B1 (de)
HU (1) HUP0100223A3 (de)
IL (1) IL136304A0 (de)
NO (1) NO323707B1 (de)
NZ (1) NZ505516A (de)
PL (1) PL190849B1 (de)
PT (1) PT1035858E (de)
RU (1) RU2207140C2 (de)
WO (1) WO1999027943A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827518B1 (fr) * 2001-07-17 2005-07-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
KR20030080623A (ko) * 2002-04-09 2003-10-17 주식회사 바이오메딕스 금연을 돕는 조성물 및 제조방법
US7169704B2 (en) 2002-06-21 2007-01-30 Samsung Electronics Co., Ltd. Method of cleaning a surface of a water in connection with forming a barrier layer of a semiconductor device
WO2005066357A1 (ja) * 2004-01-05 2005-07-21 Mitsubishi Pharma Corporation 精神疾患関連分子のスクリーニング方法
WO2007050599A2 (en) * 2005-10-27 2007-05-03 The Brigham & Women's Hospital, Inc. Ginkgolides in the treatment and prevention of ovarian cancer
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
EP2459205A1 (de) * 2009-07-28 2012-06-06 Velleja Research SRL Ginkgo-biloba-extrakt mit einem standardisierten ginkgo-flavonglykosid-gehalt ohne paf-antagonistische terpenfraktion und zusammensetzungen damit zur vorbeugung und behandlung von kreislauf-, kognitiven, geriatrischen und sensorischen erkrankungen
CN101946784B (zh) * 2010-09-26 2013-04-03 云南省农业科学院生物技术与种质资源研究所 银杏内酯b在制备抗烟草花叶病毒药物中的应用
CN112089772B (zh) * 2020-09-15 2022-02-18 汉济生物科技（武汉）有限公司 一种药物组合物及其在制备戒毒药物中的应用
CN113144021B (zh) * 2021-05-21 2022-08-19 常州工业职业技术学院 一种戒毒用中药组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE4008046C2 (de) * 1990-03-14 1999-09-16 Irbit Research & Consulting Ag Verfahren zur Herstellung eines Formteils aus Melaminharzschaumstoff
JP2924099B2 (ja) * 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
US6022889A (en) * 1991-12-23 2000-02-08 William Schwabe Gmbh & Co. Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety
JP3181356B2 (ja) * 1992-03-25 2001-07-03 ダイセル化学工業株式会社 中枢神経作用薬
DE4317868C2 (de) * 1993-05-28 1996-04-18 Arrowdean Ltd Neuartiges Anxiolytikum
JPH0753371A (ja) * 1993-08-11 1995-02-28 Daicel Chem Ind Ltd 抗痙攣薬
KR0136986B1 (ko) * 1993-12-31 1998-04-25 김준웅 신규 징코라이드 유도체와 이의 제조방법
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
GB9508533D0 (en) * 1995-04-27 1995-06-14 Sod Conseils Rech Applic Flavonoid extract of ginkgo biloba as flavouring and/or texturing agent

Also Published As

Publication number Publication date
EP1035858B1 (de) 2002-04-24
CN1280499A (zh) 2001-01-17
HUP0100223A2 (hu) 2001-10-28
NO323707B1 (no) 2007-06-25
PL340794A1 (en) 2001-02-26
ES2177097T3 (es) 2002-12-01
FR2771639B1 (fr) 2000-05-05
US6936285B1 (en) 2005-08-30
IL136304A0 (en) 2001-05-20
WO1999027943A1 (fr) 1999-06-10
NO20002775D0 (no) 2000-05-30
PT1035858E (pt) 2002-10-31
NZ505516A (en) 2001-10-26
CA2312856A1 (fr) 1999-06-10
HUP0100223A3 (en) 2004-05-28
CZ20002007A3 (cs) 2000-11-15
CN1188141C (zh) 2005-02-09
KR20010032716A (ko) 2001-04-25
DK1035858T3 (da) 2002-08-19
DE69805096D1 (de) 2002-05-29
EP1035858A1 (de) 2000-09-20
FR2771639A1 (fr) 1999-06-04
AU1438099A (en) 1999-06-16
PL190849B1 (pl) 2006-02-28
JP2001524528A (ja) 2001-12-04
CA2312856C (fr) 2009-04-07
NO20002775L (no) 2000-06-02
KR100597139B1 (ko) 2006-07-06
AU749752B2 (en) 2002-07-04
CZ299427B6 (cs) 2008-07-23
US20040180105A1 (en) 2004-09-16
RU2207140C2 (ru) 2003-06-27
DE69805096T2 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
DE69811378D1 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
ATE256463T1 (de) Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes
ATE264672T1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
EE200000503A (et) Meetod topiramaadi farmatseutilise kompositsioonivalmistamiseks, farmatseutiline kompositsioon ning topiramaadi kasutamine diabeedi raviks ette nähtud ravimi valmistamiseks
ATE216587T1 (de) Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments
DE69917477D1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
DE59604603D1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
DE60219782D1 (de) Pharmazeutische und/oder kosmetische zusammensetzung zur behandlung von lokaler adipositas und zellulitis
ATE281162T1 (de) Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose
ES2177324T3 (es) Preparaciones de insulina destinadas a la entrega pulmonar y que contiene mentol.
ATE219371T1 (de) Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen
DE60111494D1 (de) Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung
ID27023A (id) Turunan imidazola bersubstitusi bifenilsulfonil, proses penyiapannya, penggunaannya sebagai obat atau zat diagnosa dan obat yang mengandungnya
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
HUP9801236A2 (hu) Forskolin vagy ezt tartalmazó extraktum alkalmazása alkoholfüggőség kezelésére alkalmas gyógyszerkészítmény előállítására
DE69823226D1 (de) Pharmazeutische zusammmensetzung, enthaltend ticlopidin und ginkgo biloba extrakt
ATE357925T1 (de) Orale zusammensetzungen zur behandlung von cellulitis
Conley Automating regulatory compliance
ATE261309T1 (de) Verwendung von extrakten aus ginkgo biloba- blättern zur traumprovokation
ATE213167T1 (de) Alkaloidglykoside zur verwendung als arzneimittel
UA40839A (uk) Спосіб визначення ступеня сприйняття психологічного впливу у осіб чоловічої статі шляхом психохарактерологічного тестування

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner